Clinical Trial Update: Study of SOR007 Ointment for Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for SOR007 ointment in actinic keratosis; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• SOR007

Snippet

Sponsor: DFB Soria, LLC | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2019-04-25